Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Travel Restrictions Have Been Lifted, Will Medical Tourism Continue to Thrive

Why is a nurse being featured on the Say Yes to Travel podcast? Well, Kelly Greytok, RN concierge nurse specializing in plastic surgery recovery, started out as a golf course coordinator straight out of college and then became a nurse. Greytok explained to Host Sarah Dandashy that she combined her love for travel with…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Why is a nurse being featured on the Say Yes to Travel podcast? Well, Kelly Greytok, RN concierge nurse specializing in plastic surgery recovery, started out as a golf course coordinator straight out of college and then became a nurse. Greytok explained to Host Sarah Dandashy that she combined her love for travel with nursing by helping plastic surgery patients recover in hotels. She proudly maintains the motto of “exceeding the expectations of every guest every time.”

However, as one can imagine, the pandemic made Greytok’s job a little tricky with traveling and elective plastic surgeries nearly coming to a halt. Alternatively, plastic surgeons pivoted and adapted quickly, like hosting Zoom consultation sessions, and Greytok is ecstatic to see that change lasting.

Just in the U.S. this year alone, surgeons performed 15.6M cosmetic and almost 6M reconstructive surgeries, even with COVID-19 regulations. Greytok has noticed an increase in surgeries above the neck and believes it’s largely due to looking at oneself so frequently on Zoom meetings.

Greytok added that patients desire a seamless experience and the most qualified doctors since there is a hefty price tag associated with plastic surgery.

“More than ever, especially since the pandemic, people want safety, they want comfort, and they want connection,” explained Greytok. “And so I’m finding that instead of being at a house with all the other people and the crossover of nurses, they want to be in a private, luxurious hotel room… they want the privacy, and they want the great experience on their own terms.”

Interested in more information and tips on plastic surgery caregiving? Subscribe to the channel and check out Greytok’s website for bookings, videos, checklists and other resources.

More Like This Story:

Will Ecotourism Factor in to Peoples Travel Plans in 2022?

Are Increasing Healthcare Costs Driving Medical Tourism?

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512